

Price To Earnings Ratio 9.40 | Sector PE 31.86 |
PB Ratio 1.90 | Sector PB 5.87 |
EPS 85.96 | Dividend Yield 0.75 |
Today's Volume 284.615 K | 5 Day Avg. Volume 626.271 K |
PEG Ratio 0.26 | Market Cap. ₹ 14,560.00 Cr. |


Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.